Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
August 30, 2022
Atherosclerosis and the coronary artery disease that progresses with it is the most common cause of heart failure. In Poland, more than 700k patients suffer from it, leading to the death of nearly 60k people a year. It is a disease that affects large and medium-sized arterial vessels. The mechanism of atherosclerosis is related to local lipid deposition inside the vessel wall and the formation of atherosclerotic plaque, which causes thickening of the wall, narrowing of the artery, as a result of which the vascular flow can be significantly reduced.
Most common symptoms of this disease are:
– worse exercise tolerance, shortness of breath, chest pains (so-called coronary pains)
– dizziness, disorientation, transient difficulty speaking, temporary paresis
– abdominal pains
– pain in the calves (known as “stopping chrome“), cramps, swelling in the legs and feet, tingling
– kidney failure, severe hypertension.
Symptoms depend on the type of atherosclerosis. Prevention involving, among others, a healthy diet, regular physical activity and giving up stimulants is essential. It will reduce the risk of dangerous consequences, such as heart attack, stroke or lower limb amputation.
Early diagnostics offer the chance to improve prognosis and implement an appropriate treatment plan as soon as possible.
Intended Use:
Cardiolens FFR-CT Pro is a coronary physiologic simulation software for the clinical quantitative and qualitative analysis of previously acquired Coronary Computed Tomography Angiography (CCTA) and optionally with Continuous Non-invasive Blood Pressure (CNBP) data for assessment of patients with suspected Chronic Coronary Syndromes (CCS). It provides hemodynamic diagnostic factor FFR-CT (Fractional Flow Reserve with Computed Tomography), a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images and optionally from CNBP measurement. The factor FFR-CT at the output of Cardiolens FFR-CT Pro device is intended to support the functional evaluation of coronary artery disease. The Cardiolens FFR-CT Pro outputs are provided to support qualified clinicians to aid in the evaluation and assessment of coronary arteries. The results of Cardiolens FFR-CT Pro are intended to be used by qualified clinicians in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgment.